Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07151677 · ClinicalTrials.gov registry record · NA

Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia

A NA study of Stroke, Ischemic and Aphasia Following Cerebral Infarction, sponsored by Syracuse University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT07151677: Recruiting NA study of Stroke, Ischemic and Aphasia Following Cerebral Infarction, sponsored by Syracuse University.

NCT07151677 is a NA study of Stroke, Ischemic and Aphasia Following Cerebral Infarction that is actively recruiting participants, run by Syracuse University. The registered enrollment target is 60 participants, below the 288-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07151677, a NA study of Stroke, Ischemic and Aphasia Following Cerebral Infarction, is actively recruiting participants, sponsored by Syracuse University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to determine if electrical brain stimulation applied to the front parts of the brain can help people who have had a stroke improve their fatigue, language, and attention. The main question it aims to answer is: * Does transcranial direct current stimulation (tDCS) administered to the pre-frontal areas of the brain improve post-stroke fatigue and aphasia? * What kinds of participant characteristics are associated with better improvement of post-stroke fatigue and aphasia? Researchers will compare active electrical stimulation to sham stimulation to see if the active stimulation does a better job at reducing fatigue and language deficits after stroke. Participants will be asked to complete fatigue, language, and cognitive testing before and after receiving 10 sessions of tDCS plus speech and language therapy.

Primary Outcome

Scale from 1-7, higher scores mean more significant fatigue

Interventions

  • DEVICE tDCS (active)
  • BEHAVIORAL Attention-focused sentence comprehension treatment
  • BEHAVIORAL Sentence comprehension treatment
  • DEVICE tDCS (sham)

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor

New York

  • Syracuse University - Syracuse

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-08-04
Est. Completion 2029-11
Phase NA
Syracuse University

31 total trials

What NCT07151677 shows while recruiting

NCT07151677 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 288-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (79% lower).

The record links to 3 conditions, with Stroke, Ischemic appearing as the primary indexed condition, and to 4 interventions - of which tDCS (active) is the first listed.

NCT07151677 reports a single indexed study location in Michigan, New York.

Frequently Asked Questions

What is clinical trial NCT07151677 about?

NCT07151677 is a clinical study titled "Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia". The goal of this clinical trial is to determine if electrical brain stimulation applied to the front parts of the brain can help people who have had a stroke improve their fatigue, language, and attention. The main question it aims to answer is: * Does transcranial direct current stimulation (tDCS)...

What is the current status of trial NCT07151677?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-04. Estimated completion is 2029-11.

What conditions does trial NCT07151677 study?

This clinical trial studies the following conditions: Stroke, Ischemic, Aphasia Following Cerebral Infarction, Fatigue Symptom.

What interventions are being tested in trial NCT07151677?

The interventions under investigation include: tDCS (active) (DEVICE), Attention-focused sentence comprehension treatment (BEHAVIORAL), Sentence comprehension treatment (BEHAVIORAL), tDCS (sham) (DEVICE).

Who is sponsoring clinical trial NCT07151677?

This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07151677 being conducted?

This trial has 2 study locations across Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke, Ischemic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07151677's enrollment target sits among peer trials

60 18th of 33 higher than 13 of 33 other Stroke, Ischemic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07151677, the US trial registry maintained by the National Library of Medicine. NCT07151677 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.